Emergence of Resistance to Protease Inhibitor Amprenavir in Human Immunodeficiency Virus Type 1-Infected Patients: Selection of Four Alternative Viral Protease Genotypes and Influence of Viral Susceptibility to Coadministered Reverse Transcriptase Nucleoside Inhibitors

類似資料

• The ex vivo human placental transfer of the anti-HIV nucleoside inhibitor abacavir and the protease inhibitor amprenavir.
  著者:: Bawdon, R E
  出版事項: (1998)
• Metabolic Abnormalities Associated with the Use of Protease Inhibitors and Non-nucleoside Reverse Transcriptase Inhibitors
  著者:: Rao, Madhu N., 等
  出版事項: (2006)
• Use of Protease Inhibitors and Non-Nucleoside Reverse Transcriptase Inhibitors Among Medicaid Beneficiaries With AIDS
  著者:: Sambamoorthi, Usha, 等
  出版事項: (2001)
• Sociodemographic Factors Predict Early Discontinuation of HIV Non-Nucleoside Reverse Transcriptase Inhibitors and Protease Inhibitors
  著者:: Asad, Shaheena, 等
  出版事項: (2008)
• Single-Dose Pharmacokinetics of Amprenavir Coadministered with Grapefruit Juice
  著者:: Demarles, D., 等
  出版事項: (2002)